Drug Type ASO |
Synonyms- |
Target |
Action- |
Mechanism OTCase inhibitors(Ornithine carbamoyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ornithine Carbamoyltransferase Deficiency Disease | Preclinical | United States | ![]() | 26 Sep 2021 |